Moncef Slaoui

Dr. Moncef Slaoui serves as Partner & Member of Scientific Advisory Board at Medicxi. He also is an Angel Investor. He formerly served as President, Chairman & Head of Research and Development of Vaccines Division at GSK. He has extensive clinical, medical, scientific and leadership experience, gained during his 28 years at GSK, to the Medicxi team. In his role as head of R&D at GSK between 2006 and 2014, Dr Slaoui was the architect of a pioneering re-organization of the Company's R&D effort, operating through focused discreet discovery performance units (DPUs) in early stage, which competed internally for R&D investment, a unique model amongst Big Pharma at the time. As a member of the Scientific Advisory Boards of both the IL6 and MV1 venture funds, Dr Slaoui has been closely involved with Medicxi (and previously Index Ventures) for many years. As a Partner he is responsible for sponsoring and supporting investments, undertaking due diligence and valuations for Medicxi's venture fund MV1 and its growth fund MG1. He is Chairman of the board at Galvani Bioelectronics